These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9973856)

  • 21. Adjunctive benefits from low-molecular-weight heparins as compared to unfractionated heparin among patients with ST-segment elevation myocardial infarction treated with thrombolysis. A meta-analysis of the randomized trials.
    De Luca G; Marino P
    Am Heart J; 2007 Dec; 154(6):1085.e1-6. PubMed ID: 18035079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25).
    Antman EM; Morrow DA; McCabe CH; Jiang F; White HD; Fox KA; Sharma D; Chew P; Braunwald E;
    Am Heart J; 2005 Feb; 149(2):217-26. PubMed ID: 15846258
    [No Abstract]   [Full Text] [Related]  

  • 23. [Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study].
    Franzosi MG
    Ital Heart J Suppl; 2001 Sep; 2(9):1034-6. PubMed ID: 11675828
    [No Abstract]   [Full Text] [Related]  

  • 24. An overview of the thrombolysis and angioplasty in acute myocardial infarction (TAMI) trials.
    Topol EJ
    Arch Mal Coeur Vaiss; 1988 May; 81 Spec No():45-9. PubMed ID: 2973302
    [No Abstract]   [Full Text] [Related]  

  • 25. Clarifying the conundrum of conjunctive anticoagulation and coronary thrombolysis.
    Sobel BE
    Coron Artery Dis; 1995 Jan; 6(1):83-6. PubMed ID: 7767507
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment after myocardial infarction. Is rapid administration of t-PA + heparin most effective?].
    Wirschubsky Z
    Lakartidningen; 1993 Jun; 90(23):2240. PubMed ID: 8502089
    [No Abstract]   [Full Text] [Related]  

  • 27. Coronary thrombolysis and gender.
    Vine DL
    Kans Med; 1990 Mar; 91(3):83-4. PubMed ID: 2110597
    [No Abstract]   [Full Text] [Related]  

  • 28. Coronary thrombolysis: prehospital use.
    Theroux P
    Can J Cardiol; 1993; 9(6):521-2. PubMed ID: 8221348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Thrombolytic treatment of acute myocardial infarct. 2].
    Soares-Costa TJ; Gabriel HM; Soares-Costa JT
    Acta Med Port; 1998 May; 11(5):421-9. PubMed ID: 9951052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of heparin and aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction.
    N Engl J Med; 1991 Apr; 324(17):1217-8. PubMed ID: 1901380
    [No Abstract]   [Full Text] [Related]  

  • 31. Future of reperfusion therapy for acute myocardial infarction.
    White HD
    Lancet; 1999 Aug; 354(9180):695-7. PubMed ID: 10475175
    [No Abstract]   [Full Text] [Related]  

  • 32. The thrombolysis in myocardial infarction (TIMI) trial.
    Ganz W
    N Engl J Med; 1985 Oct; 313(16):1018. PubMed ID: 3930960
    [No Abstract]   [Full Text] [Related]  

  • 33. [Thrombolysis in acute myocardial infarct].
    Görge G; Erbel R
    Dtsch Med Wochenschr; 1994 May; 119(19):717. PubMed ID: 8187628
    [No Abstract]   [Full Text] [Related]  

  • 34. [The identification of the best thrombolytic. Reflections on a problem without resolution].
    Betriu A
    Rev Esp Cardiol; 1993 Apr; 46(4):242-5. PubMed ID: 8469809
    [No Abstract]   [Full Text] [Related]  

  • 35. Thrombolytic therapy for acute myocardial infarction.
    Ross AM
    Cardiovasc Clin; 1989; 20(1):209-18. PubMed ID: 2653634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombolytic therapy for acute myocardial infarction.
    Meister FL; Stringer KA; Spinler SA; Gonzalez E; Talbert RL; Weiner B; Guerrero RM; Smith R
    Pharmacotherapy; 1998; 18(4):686-98. PubMed ID: 9692643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombolysis in the era of the randomized trials.
    Zahger D; Gotsman MS
    Curr Opin Cardiol; 1995 Jul; 10(4):372-80. PubMed ID: 7549079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coronary thrombolysis--a perspective for the practicing physician.
    Fuster V
    N Engl J Med; 1993 Sep; 329(10):723-5. PubMed ID: 8345859
    [No Abstract]   [Full Text] [Related]  

  • 39. Stroke: advances in thrombolysis.
    Kaste M
    Lancet Neurol; 2013 Jan; 12(1):2-4. PubMed ID: 23237887
    [No Abstract]   [Full Text] [Related]  

  • 40. New fibrinolytic agents for MI: as effective as current agents, but easier to administer.
    Ellis K; Brener S
    Cleve Clin J Med; 2004 Jan; 71(1):20, 23-5, 29-30 passim. PubMed ID: 14740966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.